nodes	percent_of_prediction	percent_of_DWPC	metapath
Dihydrocodeine—CYP2D6—Captopril—systemic scleroderma	0.0726	0.526	CbGbCtD
Dihydrocodeine—CYP3A4—Mycophenolate mofetil—systemic scleroderma	0.0363	0.263	CbGbCtD
Dihydrocodeine—CYP3A4—Prednisone—systemic scleroderma	0.029	0.211	CbGbCtD
Dihydrocodeine—Mood swings—Mycophenolate mofetil—systemic scleroderma	0.00516	0.00598	CcSEcCtD
Dihydrocodeine—Dyspnoea—Pentoxifylline—systemic scleroderma	0.00507	0.00588	CcSEcCtD
Dihydrocodeine—Somnolence—Pentoxifylline—systemic scleroderma	0.00506	0.00587	CcSEcCtD
Dihydrocodeine—Hepatobiliary disease—Mycophenolic acid—systemic scleroderma	0.00503	0.00583	CcSEcCtD
Dihydrocodeine—Dry mouth—Mometasone—systemic scleroderma	0.00501	0.00581	CcSEcCtD
Dihydrocodeine—Urinary tract disorder—Leflunomide—systemic scleroderma	0.00494	0.00573	CcSEcCtD
Dihydrocodeine—Urethral disorder—Leflunomide—systemic scleroderma	0.0049	0.00569	CcSEcCtD
Dihydrocodeine—Constipation—Pentoxifylline—systemic scleroderma	0.00486	0.00564	CcSEcCtD
Dihydrocodeine—Angioedema—Captopril—systemic scleroderma	0.00483	0.0056	CcSEcCtD
Dihydrocodeine—Immune system disorder—Azathioprine—systemic scleroderma	0.00478	0.00555	CcSEcCtD
Dihydrocodeine—Mediastinal disorder—Azathioprine—systemic scleroderma	0.00477	0.00554	CcSEcCtD
Dihydrocodeine—Hallucination—Mycophenolic acid—systemic scleroderma	0.00475	0.00551	CcSEcCtD
Dihydrocodeine—Urinary tract disorder—Mycophenolic acid—systemic scleroderma	0.00471	0.00547	CcSEcCtD
Dihydrocodeine—Feeling abnormal—Pentoxifylline—systemic scleroderma	0.00469	0.00544	CcSEcCtD
Dihydrocodeine—Urethral disorder—Mycophenolic acid—systemic scleroderma	0.00468	0.00543	CcSEcCtD
Dihydrocodeine—Gastrointestinal pain—Pentoxifylline—systemic scleroderma	0.00465	0.0054	CcSEcCtD
Dihydrocodeine—Hepatobiliary disease—Lisinopril—systemic scleroderma	0.00453	0.00525	CcSEcCtD
Dihydrocodeine—Urticaria—Pentoxifylline—systemic scleroderma	0.00452	0.00524	CcSEcCtD
Dihydrocodeine—Immune system disorder—Leflunomide—systemic scleroderma	0.00452	0.00524	CcSEcCtD
Dihydrocodeine—Mediastinal disorder—Leflunomide—systemic scleroderma	0.00451	0.00523	CcSEcCtD
Dihydrocodeine—Abdominal pain—Pentoxifylline—systemic scleroderma	0.0045	0.00522	CcSEcCtD
Dihydrocodeine—Hepatic enzyme increased—Methotrexate—systemic scleroderma	0.00449	0.00521	CcSEcCtD
Dihydrocodeine—Paraesthesia—Mometasone—systemic scleroderma	0.00441	0.00511	CcSEcCtD
Dihydrocodeine—Dry mouth—Captopril—systemic scleroderma	0.0044	0.0051	CcSEcCtD
Dihydrocodeine—Mental disorder—Leflunomide—systemic scleroderma	0.00438	0.00508	CcSEcCtD
Dihydrocodeine—Dyspnoea—Mometasone—systemic scleroderma	0.00438	0.00508	CcSEcCtD
Dihydrocodeine—Confusional state—Captopril—systemic scleroderma	0.00435	0.00504	CcSEcCtD
Dihydrocodeine—Angiopathy—Mycophenolic acid—systemic scleroderma	0.00433	0.00502	CcSEcCtD
Dihydrocodeine—Mediastinal disorder—Mycophenolic acid—systemic scleroderma	0.0043	0.00499	CcSEcCtD
Dihydrocodeine—Hallucination—Lisinopril—systemic scleroderma	0.00428	0.00496	CcSEcCtD
Dihydrocodeine—Urinary tract disorder—Lisinopril—systemic scleroderma	0.00424	0.00492	CcSEcCtD
Dihydrocodeine—Urethral disorder—Lisinopril—systemic scleroderma	0.00421	0.00489	CcSEcCtD
Dihydrocodeine—Mental disorder—Mycophenolic acid—systemic scleroderma	0.00418	0.00485	CcSEcCtD
Dihydrocodeine—Hypotension—Captopril—systemic scleroderma	0.00403	0.00467	CcSEcCtD
Dihydrocodeine—Pruritus—Pentoxifylline—systemic scleroderma	0.00402	0.00467	CcSEcCtD
Dihydrocodeine—Gastrointestinal pain—Mometasone—systemic scleroderma	0.00401	0.00466	CcSEcCtD
Dihydrocodeine—Angioedema—Leflunomide—systemic scleroderma	0.00398	0.00461	CcSEcCtD
Dihydrocodeine—Hepatobiliary disease—Mycophenolate mofetil—systemic scleroderma	0.00397	0.0046	CcSEcCtD
Dihydrocodeine—Vertigo—Leflunomide—systemic scleroderma	0.00391	0.00454	CcSEcCtD
Dihydrocodeine—Angiopathy—Lisinopril—systemic scleroderma	0.0039	0.00452	CcSEcCtD
Dihydrocodeine—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—systemic scleroderma	0.0039	0.00452	CcSEcCtD
Dihydrocodeine—Diarrhoea—Pentoxifylline—systemic scleroderma	0.00389	0.00451	CcSEcCtD
Dihydrocodeine—Abdominal pain—Mometasone—systemic scleroderma	0.00388	0.0045	CcSEcCtD
Dihydrocodeine—Mediastinal disorder—Lisinopril—systemic scleroderma	0.00387	0.00449	CcSEcCtD
Dihydrocodeine—Paraesthesia—Captopril—systemic scleroderma	0.00387	0.00449	CcSEcCtD
Dihydrocodeine—Dyspnoea—Captopril—systemic scleroderma	0.00384	0.00446	CcSEcCtD
Dihydrocodeine—Somnolence—Captopril—systemic scleroderma	0.00383	0.00445	CcSEcCtD
Dihydrocodeine—Mental disorder—Lisinopril—systemic scleroderma	0.00376	0.00437	CcSEcCtD
Dihydrocodeine—Dizziness—Pentoxifylline—systemic scleroderma	0.00376	0.00436	CcSEcCtD
Dihydrocodeine—Hallucination—Mycophenolate mofetil—systemic scleroderma	0.00375	0.00435	CcSEcCtD
Dihydrocodeine—Vertigo—Mycophenolic acid—systemic scleroderma	0.00373	0.00433	CcSEcCtD
Dihydrocodeine—Urinary tract disorder—Mycophenolate mofetil—systemic scleroderma	0.00372	0.00431	CcSEcCtD
Dihydrocodeine—Urethral disorder—Mycophenolate mofetil—systemic scleroderma	0.00369	0.00428	CcSEcCtD
Dihydrocodeine—Constipation—Captopril—systemic scleroderma	0.00369	0.00428	CcSEcCtD
Dihydrocodeine—Unspecified disorder of skin and subcutaneous tissue—Leflunomide—systemic scleroderma	0.00368	0.00427	CcSEcCtD
Dihydrocodeine—Skin disorder—Azathioprine—systemic scleroderma	0.00365	0.00424	CcSEcCtD
Dihydrocodeine—Affect lability—Prednisone—systemic scleroderma	0.00363	0.00421	CcSEcCtD
Dihydrocodeine—Dry mouth—Leflunomide—systemic scleroderma	0.00362	0.0042	CcSEcCtD
Dihydrocodeine—Vomiting—Pentoxifylline—systemic scleroderma	0.00362	0.0042	CcSEcCtD
Dihydrocodeine—Convulsion—Mycophenolic acid—systemic scleroderma	0.0036	0.00417	CcSEcCtD
Dihydrocodeine—Rash—Pentoxifylline—systemic scleroderma	0.00359	0.00416	CcSEcCtD
Dihydrocodeine—Dermatitis—Pentoxifylline—systemic scleroderma	0.00358	0.00416	CcSEcCtD
Dihydrocodeine—Headache—Pentoxifylline—systemic scleroderma	0.00356	0.00413	CcSEcCtD
Dihydrocodeine—Feeling abnormal—Captopril—systemic scleroderma	0.00355	0.00412	CcSEcCtD
Dihydrocodeine—Gastrointestinal pain—Captopril—systemic scleroderma	0.00353	0.00409	CcSEcCtD
Dihydrocodeine—Hypotension—Azathioprine—systemic scleroderma	0.00352	0.00408	CcSEcCtD
Dihydrocodeine—Unspecified disorder of skin and subcutaneous tissue—Mycophenolic acid—systemic scleroderma	0.00351	0.00407	CcSEcCtD
Dihydrocodeine—Mood swings—Prednisone—systemic scleroderma	0.00349	0.00405	CcSEcCtD
Dihydrocodeine—Nervous system disorder—Leflunomide—systemic scleroderma	0.00348	0.00404	CcSEcCtD
Dihydrocodeine—Pruritus—Mometasone—systemic scleroderma	0.00347	0.00403	CcSEcCtD
Dihydrocodeine—Dry mouth—Mycophenolic acid—systemic scleroderma	0.00346	0.00401	CcSEcCtD
Dihydrocodeine—Skin disorder—Leflunomide—systemic scleroderma	0.00345	0.004	CcSEcCtD
Dihydrocodeine—Hyperhidrosis—Leflunomide—systemic scleroderma	0.00343	0.00398	CcSEcCtD
Dihydrocodeine—Angioedema—Lisinopril—systemic scleroderma	0.00342	0.00397	CcSEcCtD
Dihydrocodeine—Confusional state—Mycophenolic acid—systemic scleroderma	0.00342	0.00396	CcSEcCtD
Dihydrocodeine—Angiopathy—Mycophenolate mofetil—systemic scleroderma	0.00342	0.00396	CcSEcCtD
Dihydrocodeine—Abdominal pain—Captopril—systemic scleroderma	0.00341	0.00395	CcSEcCtD
Dihydrocodeine—Mediastinal disorder—Mycophenolate mofetil—systemic scleroderma	0.00339	0.00394	CcSEcCtD
Dihydrocodeine—Nausea—Pentoxifylline—systemic scleroderma	0.00338	0.00392	CcSEcCtD
Dihydrocodeine—Vertigo—Lisinopril—systemic scleroderma	0.00336	0.0039	CcSEcCtD
Dihydrocodeine—Diarrhoea—Mometasone—systemic scleroderma	0.00336	0.0039	CcSEcCtD
Dihydrocodeine—Nervous system disorder—Mycophenolic acid—systemic scleroderma	0.00332	0.00386	CcSEcCtD
Dihydrocodeine—Hypotension—Leflunomide—systemic scleroderma	0.00332	0.00385	CcSEcCtD
Dihydrocodeine—Mental disorder—Mycophenolate mofetil—systemic scleroderma	0.0033	0.00383	CcSEcCtD
Dihydrocodeine—Skin disorder—Mycophenolic acid—systemic scleroderma	0.00329	0.00382	CcSEcCtD
Dihydrocodeine—Hyperhidrosis—Mycophenolic acid—systemic scleroderma	0.00328	0.0038	CcSEcCtD
Dihydrocodeine—Gastrointestinal disorder—Azathioprine—systemic scleroderma	0.00325	0.00377	CcSEcCtD
Dihydrocodeine—Paraesthesia—Leflunomide—systemic scleroderma	0.00319	0.0037	CcSEcCtD
Dihydrocodeine—Dyspnoea—Leflunomide—systemic scleroderma	0.00317	0.00367	CcSEcCtD
Dihydrocodeine—Hypotension—Mycophenolic acid—systemic scleroderma	0.00317	0.00367	CcSEcCtD
Dihydrocodeine—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—systemic scleroderma	0.00316	0.00367	CcSEcCtD
Dihydrocodeine—Vomiting—Mometasone—systemic scleroderma	0.00312	0.00362	CcSEcCtD
Dihydrocodeine—Dry mouth—Lisinopril—systemic scleroderma	0.00311	0.00361	CcSEcCtD
Dihydrocodeine—Feeling abnormal—Azathioprine—systemic scleroderma	0.0031	0.0036	CcSEcCtD
Dihydrocodeine—Rash—Mometasone—systemic scleroderma	0.00309	0.00359	CcSEcCtD
Dihydrocodeine—Dermatitis—Mometasone—systemic scleroderma	0.00309	0.00359	CcSEcCtD
Dihydrocodeine—Confusional state—Lisinopril—systemic scleroderma	0.00308	0.00357	CcSEcCtD
Dihydrocodeine—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.00308	0.00357	CcSEcCtD
Dihydrocodeine—Headache—Mometasone—systemic scleroderma	0.00307	0.00357	CcSEcCtD
Dihydrocodeine—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.00307	0.00356	CcSEcCtD
Dihydrocodeine—Pruritus—Captopril—systemic scleroderma	0.00305	0.00354	CcSEcCtD
Dihydrocodeine—Paraesthesia—Mycophenolic acid—systemic scleroderma	0.00304	0.00353	CcSEcCtD
Dihydrocodeine—Constipation—Leflunomide—systemic scleroderma	0.00304	0.00352	CcSEcCtD
Dihydrocodeine—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.00302	0.00351	CcSEcCtD
Dihydrocodeine—Somnolence—Mycophenolic acid—systemic scleroderma	0.00301	0.0035	CcSEcCtD
Dihydrocodeine—Angioedema—Mycophenolate mofetil—systemic scleroderma	0.00299	0.00347	CcSEcCtD
Dihydrocodeine—Abdominal pain—Azathioprine—systemic scleroderma	0.00297	0.00345	CcSEcCtD
Dihydrocodeine—Skin disorder—Lisinopril—systemic scleroderma	0.00297	0.00344	CcSEcCtD
Dihydrocodeine—Hyperhidrosis—Lisinopril—systemic scleroderma	0.00295	0.00342	CcSEcCtD
Dihydrocodeine—Diarrhoea—Captopril—systemic scleroderma	0.00295	0.00342	CcSEcCtD
Dihydrocodeine—Vertigo—Mycophenolate mofetil—systemic scleroderma	0.00294	0.00342	CcSEcCtD
Dihydrocodeine—Feeling abnormal—Leflunomide—systemic scleroderma	0.00293	0.0034	CcSEcCtD
Dihydrocodeine—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.00293	0.00339	CcSEcCtD
Dihydrocodeine—Mood swings—Methotrexate—systemic scleroderma	0.00292	0.00339	CcSEcCtD
Dihydrocodeine—Nausea—Mometasone—systemic scleroderma	0.00292	0.00338	CcSEcCtD
Dihydrocodeine—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.00291	0.00337	CcSEcCtD
Dihydrocodeine—Constipation—Mycophenolic acid—systemic scleroderma	0.0029	0.00336	CcSEcCtD
Dihydrocodeine—Hypotension—Lisinopril—systemic scleroderma	0.00285	0.00331	CcSEcCtD
Dihydrocodeine—Dizziness—Captopril—systemic scleroderma	0.00285	0.00331	CcSEcCtD
Dihydrocodeine—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.00284	0.00329	CcSEcCtD
Dihydrocodeine—Urticaria—Leflunomide—systemic scleroderma	0.00282	0.00327	CcSEcCtD
Dihydrocodeine—Abdominal pain—Leflunomide—systemic scleroderma	0.00281	0.00326	CcSEcCtD
Dihydrocodeine—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.00279	0.00324	CcSEcCtD
Dihydrocodeine—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.00277	0.00322	CcSEcCtD
Dihydrocodeine—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.00277	0.00321	CcSEcCtD
Dihydrocodeine—Paraesthesia—Lisinopril—systemic scleroderma	0.00274	0.00318	CcSEcCtD
Dihydrocodeine—Vomiting—Captopril—systemic scleroderma	0.00274	0.00318	CcSEcCtD
Dihydrocodeine—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.00273	0.00317	CcSEcCtD
Dihydrocodeine—Dyspnoea—Lisinopril—systemic scleroderma	0.00272	0.00316	CcSEcCtD
Dihydrocodeine—Rash—Captopril—systemic scleroderma	0.00272	0.00315	CcSEcCtD
Dihydrocodeine—Dermatitis—Captopril—systemic scleroderma	0.00272	0.00315	CcSEcCtD
Dihydrocodeine—Somnolence—Lisinopril—systemic scleroderma	0.00271	0.00315	CcSEcCtD
Dihydrocodeine—Headache—Captopril—systemic scleroderma	0.0027	0.00313	CcSEcCtD
Dihydrocodeine—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.0027	0.00313	CcSEcCtD
Dihydrocodeine—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.00268	0.00311	CcSEcCtD
Dihydrocodeine—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.00264	0.00306	CcSEcCtD
Dihydrocodeine—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.00262	0.00304	CcSEcCtD
Dihydrocodeine—Constipation—Lisinopril—systemic scleroderma	0.00261	0.00303	CcSEcCtD
Dihydrocodeine—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.0026	0.00301	CcSEcCtD
Dihydrocodeine—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.00259	0.003	CcSEcCtD
Dihydrocodeine—Diarrhoea—Azathioprine—systemic scleroderma	0.00257	0.00299	CcSEcCtD
Dihydrocodeine—Nausea—Captopril—systemic scleroderma	0.00256	0.00297	CcSEcCtD
Dihydrocodeine—Hallucination—Prednisone—systemic scleroderma	0.00254	0.00295	CcSEcCtD
Dihydrocodeine—Feeling abnormal—Lisinopril—systemic scleroderma	0.00252	0.00292	CcSEcCtD
Dihydrocodeine—Pruritus—Leflunomide—systemic scleroderma	0.00251	0.00292	CcSEcCtD
Dihydrocodeine—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.0025	0.0029	CcSEcCtD
Dihydrocodeine—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.0025	0.0029	CcSEcCtD
Dihydrocodeine—Dizziness—Azathioprine—systemic scleroderma	0.00249	0.00289	CcSEcCtD
Dihydrocodeine—Diarrhoea—Leflunomide—systemic scleroderma	0.00243	0.00282	CcSEcCtD
Dihydrocodeine—Urticaria—Lisinopril—systemic scleroderma	0.00243	0.00281	CcSEcCtD
Dihydrocodeine—Abdominal pain—Lisinopril—systemic scleroderma	0.00241	0.0028	CcSEcCtD
Dihydrocodeine—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.0024	0.00279	CcSEcCtD
Dihydrocodeine—Pruritus—Mycophenolic acid—systemic scleroderma	0.0024	0.00278	CcSEcCtD
Dihydrocodeine—Vomiting—Azathioprine—systemic scleroderma	0.00239	0.00277	CcSEcCtD
Dihydrocodeine—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.00238	0.00277	CcSEcCtD
Dihydrocodeine—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.00238	0.00276	CcSEcCtD
Dihydrocodeine—Rash—Azathioprine—systemic scleroderma	0.00237	0.00275	CcSEcCtD
Dihydrocodeine—Dermatitis—Azathioprine—systemic scleroderma	0.00237	0.00275	CcSEcCtD
Dihydrocodeine—Headache—Azathioprine—systemic scleroderma	0.00236	0.00273	CcSEcCtD
Dihydrocodeine—Dizziness—Leflunomide—systemic scleroderma	0.00235	0.00273	CcSEcCtD
Dihydrocodeine—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.00232	0.00269	CcSEcCtD
Dihydrocodeine—Angiopathy—Prednisone—systemic scleroderma	0.00232	0.00269	CcSEcCtD
Dihydrocodeine—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.00231	0.00268	CcSEcCtD
Dihydrocodeine—Immune system disorder—Prednisone—systemic scleroderma	0.00231	0.00267	CcSEcCtD
Dihydrocodeine—Constipation—Mycophenolate mofetil—systemic scleroderma	0.00229	0.00265	CcSEcCtD
Dihydrocodeine—Vomiting—Leflunomide—systemic scleroderma	0.00226	0.00262	CcSEcCtD
Dihydrocodeine—Hepatobiliary disease—Methotrexate—systemic scleroderma	0.00225	0.00261	CcSEcCtD
Dihydrocodeine—Dizziness—Mycophenolic acid—systemic scleroderma	0.00224	0.0026	CcSEcCtD
Dihydrocodeine—Rash—Leflunomide—systemic scleroderma	0.00224	0.0026	CcSEcCtD
Dihydrocodeine—Dermatitis—Leflunomide—systemic scleroderma	0.00224	0.0026	CcSEcCtD
Dihydrocodeine—Mental disorder—Prednisone—systemic scleroderma	0.00224	0.00259	CcSEcCtD
Dihydrocodeine—Nausea—Azathioprine—systemic scleroderma	0.00223	0.00259	CcSEcCtD
Dihydrocodeine—Headache—Leflunomide—systemic scleroderma	0.00223	0.00258	CcSEcCtD
Dihydrocodeine—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.0022	0.00256	CcSEcCtD
Dihydrocodeine—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.00219	0.00254	CcSEcCtD
Dihydrocodeine—Pruritus—Lisinopril—systemic scleroderma	0.00216	0.00251	CcSEcCtD
Dihydrocodeine—Vomiting—Mycophenolic acid—systemic scleroderma	0.00216	0.0025	CcSEcCtD
Dihydrocodeine—Rash—Mycophenolic acid—systemic scleroderma	0.00214	0.00248	CcSEcCtD
Dihydrocodeine—Dermatitis—Mycophenolic acid—systemic scleroderma	0.00214	0.00248	CcSEcCtD
Dihydrocodeine—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.00212	0.00247	CcSEcCtD
Dihydrocodeine—Headache—Mycophenolic acid—systemic scleroderma	0.00212	0.00246	CcSEcCtD
Dihydrocodeine—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.00211	0.00245	CcSEcCtD
Dihydrocodeine—Nausea—Leflunomide—systemic scleroderma	0.00211	0.00245	CcSEcCtD
Dihydrocodeine—Urinary tract disorder—Methotrexate—systemic scleroderma	0.00211	0.00244	CcSEcCtD
Dihydrocodeine—Urethral disorder—Methotrexate—systemic scleroderma	0.00209	0.00243	CcSEcCtD
Dihydrocodeine—Diarrhoea—Lisinopril—systemic scleroderma	0.00209	0.00242	CcSEcCtD
Dihydrocodeine—Angioedema—Prednisone—systemic scleroderma	0.00203	0.00235	CcSEcCtD
Dihydrocodeine—Dizziness—Lisinopril—systemic scleroderma	0.00202	0.00234	CcSEcCtD
Dihydrocodeine—Nausea—Mycophenolic acid—systemic scleroderma	0.00201	0.00234	CcSEcCtD
Dihydrocodeine—Vertigo—Prednisone—systemic scleroderma	0.002	0.00232	CcSEcCtD
Dihydrocodeine—Vomiting—Lisinopril—systemic scleroderma	0.00194	0.00225	CcSEcCtD
Dihydrocodeine—Angiopathy—Methotrexate—systemic scleroderma	0.00194	0.00224	CcSEcCtD
Dihydrocodeine—Immune system disorder—Methotrexate—systemic scleroderma	0.00193	0.00223	CcSEcCtD
Dihydrocodeine—Rash—Lisinopril—systemic scleroderma	0.00192	0.00223	CcSEcCtD
Dihydrocodeine—Convulsion—Prednisone—systemic scleroderma	0.00192	0.00223	CcSEcCtD
Dihydrocodeine—Dermatitis—Lisinopril—systemic scleroderma	0.00192	0.00223	CcSEcCtD
Dihydrocodeine—Mediastinal disorder—Methotrexate—systemic scleroderma	0.00192	0.00223	CcSEcCtD
Dihydrocodeine—Headache—Lisinopril—systemic scleroderma	0.00191	0.00222	CcSEcCtD
Dihydrocodeine—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.00189	0.0022	CcSEcCtD
Dihydrocodeine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	0.00188	0.00218	CcSEcCtD
Dihydrocodeine—Mental disorder—Methotrexate—systemic scleroderma	0.00187	0.00217	CcSEcCtD
Dihydrocodeine—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.00183	0.00212	CcSEcCtD
Dihydrocodeine—Nausea—Lisinopril—systemic scleroderma	0.00181	0.0021	CcSEcCtD
Dihydrocodeine—Nervous system disorder—Prednisone—systemic scleroderma	0.00178	0.00206	CcSEcCtD
Dihydrocodeine—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.00177	0.00205	CcSEcCtD
Dihydrocodeine—Skin disorder—Prednisone—systemic scleroderma	0.00176	0.00204	CcSEcCtD
Dihydrocodeine—Hyperhidrosis—Prednisone—systemic scleroderma	0.00175	0.00203	CcSEcCtD
Dihydrocodeine—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.0017	0.00197	CcSEcCtD
Dihydrocodeine—Rash—Mycophenolate mofetil—systemic scleroderma	0.00169	0.00196	CcSEcCtD
Dihydrocodeine—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.00169	0.00195	CcSEcCtD
Dihydrocodeine—Headache—Mycophenolate mofetil—systemic scleroderma	0.00168	0.00194	CcSEcCtD
Dihydrocodeine—Vertigo—Methotrexate—systemic scleroderma	0.00167	0.00194	CcSEcCtD
Dihydrocodeine—Paraesthesia—Prednisone—systemic scleroderma	0.00163	0.00189	CcSEcCtD
Dihydrocodeine—Convulsion—Methotrexate—systemic scleroderma	0.00161	0.00187	CcSEcCtD
Dihydrocodeine—Nausea—Mycophenolate mofetil—systemic scleroderma	0.00159	0.00184	CcSEcCtD
Dihydrocodeine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	0.00157	0.00182	CcSEcCtD
Dihydrocodeine—Constipation—Prednisone—systemic scleroderma	0.00155	0.0018	CcSEcCtD
Dihydrocodeine—Confusional state—Methotrexate—systemic scleroderma	0.00153	0.00177	CcSEcCtD
Dihydrocodeine—Feeling abnormal—Prednisone—systemic scleroderma	0.00149	0.00173	CcSEcCtD
Dihydrocodeine—Nervous system disorder—Methotrexate—systemic scleroderma	0.00149	0.00172	CcSEcCtD
Dihydrocodeine—Gastrointestinal pain—Prednisone—systemic scleroderma	0.00148	0.00172	CcSEcCtD
Dihydrocodeine—Skin disorder—Methotrexate—systemic scleroderma	0.00147	0.00171	CcSEcCtD
Dihydrocodeine—Hyperhidrosis—Methotrexate—systemic scleroderma	0.00146	0.0017	CcSEcCtD
Dihydrocodeine—Urticaria—Prednisone—systemic scleroderma	0.00144	0.00167	CcSEcCtD
Dihydrocodeine—Abdominal pain—Prednisone—systemic scleroderma	0.00143	0.00166	CcSEcCtD
Dihydrocodeine—Hypotension—Methotrexate—systemic scleroderma	0.00142	0.00164	CcSEcCtD
Dihydrocodeine—Paraesthesia—Methotrexate—systemic scleroderma	0.00136	0.00158	CcSEcCtD
Dihydrocodeine—Dyspnoea—Methotrexate—systemic scleroderma	0.00135	0.00157	CcSEcCtD
Dihydrocodeine—Somnolence—Methotrexate—systemic scleroderma	0.00135	0.00156	CcSEcCtD
Dihydrocodeine—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.00131	0.00152	CcSEcCtD
Dihydrocodeine—Pruritus—Prednisone—systemic scleroderma	0.00128	0.00149	CcSEcCtD
Dihydrocodeine—Feeling abnormal—Methotrexate—systemic scleroderma	0.00125	0.00145	CcSEcCtD
Dihydrocodeine—Diarrhoea—Prednisone—systemic scleroderma	0.00124	0.00144	CcSEcCtD
Dihydrocodeine—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.00124	0.00144	CcSEcCtD
Dihydrocodeine—Urticaria—Methotrexate—systemic scleroderma	0.0012	0.0014	CcSEcCtD
Dihydrocodeine—Dizziness—Prednisone—systemic scleroderma	0.0012	0.00139	CcSEcCtD
Dihydrocodeine—Abdominal pain—Methotrexate—systemic scleroderma	0.0012	0.00139	CcSEcCtD
Dihydrocodeine—Vomiting—Prednisone—systemic scleroderma	0.00115	0.00134	CcSEcCtD
Dihydrocodeine—Rash—Prednisone—systemic scleroderma	0.00114	0.00133	CcSEcCtD
Dihydrocodeine—Dermatitis—Prednisone—systemic scleroderma	0.00114	0.00132	CcSEcCtD
Dihydrocodeine—Headache—Prednisone—systemic scleroderma	0.00114	0.00132	CcSEcCtD
Dihydrocodeine—Nausea—Prednisone—systemic scleroderma	0.00108	0.00125	CcSEcCtD
Dihydrocodeine—Pruritus—Methotrexate—systemic scleroderma	0.00107	0.00124	CcSEcCtD
Dihydrocodeine—Diarrhoea—Methotrexate—systemic scleroderma	0.00104	0.0012	CcSEcCtD
Dihydrocodeine—Dizziness—Methotrexate—systemic scleroderma	0.001	0.00116	CcSEcCtD
Dihydrocodeine—Vomiting—Methotrexate—systemic scleroderma	0.000963	0.00112	CcSEcCtD
Dihydrocodeine—Rash—Methotrexate—systemic scleroderma	0.000955	0.00111	CcSEcCtD
Dihydrocodeine—Dermatitis—Methotrexate—systemic scleroderma	0.000955	0.00111	CcSEcCtD
Dihydrocodeine—Headache—Methotrexate—systemic scleroderma	0.000949	0.0011	CcSEcCtD
Dihydrocodeine—Nausea—Methotrexate—systemic scleroderma	0.0009	0.00104	CcSEcCtD
